PYRAZINOPYRAZINES AND DERIVATIVES AS KINASE INHIBITORS

The disclosure relates to a family of pyrazinopyrazine compounds of the general formula: (see above formula) in which the variable groups are as defined herein, and to their preparation and use as kinase inhibitors and medicaments in the treatment of cancer and other diseases. L'invention conce...

Full description

Saved in:
Bibliographic Details
Main Authors HUANG, WEI-SHENG, THOMAS, R. MATHEW
Format Patent
LanguageEnglish
French
Published 18.10.2016
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The disclosure relates to a family of pyrazinopyrazine compounds of the general formula: (see above formula) in which the variable groups are as defined herein, and to their preparation and use as kinase inhibitors and medicaments in the treatment of cancer and other diseases. L'invention concerne des composés représentés par la formule générale (I), dans laquelle les groupes variables sont tels que définis dans la description, ainsi que des procédés de préparation et d'utilisation de ces composés.
Bibliography:Application Number: CA20092743449